CN1250215C - 用于预防或治疗双相性精神障碍的氨基甲酸酯化合物 - Google Patents

用于预防或治疗双相性精神障碍的氨基甲酸酯化合物 Download PDF

Info

Publication number
CN1250215C
CN1250215C CNB028089170A CN02808917A CN1250215C CN 1250215 C CN1250215 C CN 1250215C CN B028089170 A CNB028089170 A CN B028089170A CN 02808917 A CN02808917 A CN 02808917A CN 1250215 C CN1250215 C CN 1250215C
Authority
CN
China
Prior art keywords
formula
enantiomer
bipolar disorder
use according
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028089170A
Other languages
English (en)
Chinese (zh)
Other versions
CN1505506A (zh
Inventor
C·R·普拉塔-萨拉曼
赵柏羽
R·E·特伊曼
崔溶文
R·戈顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of CN1505506A publication Critical patent/CN1505506A/zh
Application granted granted Critical
Publication of CN1250215C publication Critical patent/CN1250215C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
CNB028089170A 2001-02-27 2002-02-21 用于预防或治疗双相性精神障碍的氨基甲酸酯化合物 Expired - Fee Related CN1250215C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27168101P 2001-02-27 2001-02-27
US60/271,681 2001-02-27
US10/081,766 2002-02-21
US10/081,766 US6562867B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (2)

Publication Number Publication Date
CN1505506A CN1505506A (zh) 2004-06-16
CN1250215C true CN1250215C (zh) 2006-04-12

Family

ID=26765948

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028089170A Expired - Fee Related CN1250215C (zh) 2001-02-27 2002-02-21 用于预防或治疗双相性精神障碍的氨基甲酸酯化合物

Country Status (26)

Country Link
US (1) US6562867B2 (cg-RX-API-DMAC7.html)
EP (1) EP1408953B1 (cg-RX-API-DMAC7.html)
JP (1) JP4276837B2 (cg-RX-API-DMAC7.html)
KR (1) KR100946944B1 (cg-RX-API-DMAC7.html)
CN (1) CN1250215C (cg-RX-API-DMAC7.html)
AT (1) ATE324108T1 (cg-RX-API-DMAC7.html)
BR (1) BR0207644A (cg-RX-API-DMAC7.html)
CA (1) CA2439475C (cg-RX-API-DMAC7.html)
CY (1) CY1105330T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20032300A3 (cg-RX-API-DMAC7.html)
DE (1) DE60210976T2 (cg-RX-API-DMAC7.html)
DK (1) DK1408953T3 (cg-RX-API-DMAC7.html)
ES (1) ES2262801T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0303243A3 (cg-RX-API-DMAC7.html)
IL (1) IL157590A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007717A (cg-RX-API-DMAC7.html)
MY (1) MY129304A (cg-RX-API-DMAC7.html)
NO (1) NO20033802L (cg-RX-API-DMAC7.html)
NZ (1) NZ527988A (cg-RX-API-DMAC7.html)
PL (1) PL364638A1 (cg-RX-API-DMAC7.html)
PT (1) PT1408953E (cg-RX-API-DMAC7.html)
RS (1) RS50677B (cg-RX-API-DMAC7.html)
RU (1) RU2300372C2 (cg-RX-API-DMAC7.html)
TW (1) TWI250872B (cg-RX-API-DMAC7.html)
WO (1) WO2002067921A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200307465B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ523851A (en) * 2000-07-21 2004-09-24 Ortho Mcneil Pharm Inc A method for use of carbamate enantiomers in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2002067923A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating anxiety disorders
PT1383489E (pt) * 2001-02-27 2007-06-21 Ortho Mcneil Pharm Inc Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos
BR0211244A (pt) 2001-07-16 2004-07-27 Ortho Mcneil Pharm Inc Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada com cefaléia em salvas e enxaqueca
NZ553813A (en) * 2004-09-16 2010-09-30 Janssen Pharmaceutica Nv Use of 2-phenyl-1, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy
KR101335941B1 (ko) 2005-06-08 2013-12-04 에스케이바이오팜 주식회사 수면-각성 장애의 치료
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
BRPI0718324A2 (pt) * 2006-10-30 2013-11-26 Sk Holdings Métodos para o tratamento de depressão.
CN101568333A (zh) * 2006-10-31 2009-10-28 詹森药业有限公司 广泛性发育障碍的治疗
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
KR102014615B1 (ko) * 2013-03-12 2019-08-27 (주)바이오팜솔루션즈 페닐카바메이트 화합물 및 이를 포함하는 신경보호용 조성물
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
KR102635938B1 (ko) * 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
BR112019025286A2 (pt) 2017-06-02 2020-06-23 Jazz Pharmaceuticals Ireland Limited Métodos e composições para tratamento de sonolência excessiva
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
CN1056611C (zh) * 1994-06-16 2000-09-20 美国辉瑞有限公司 吡唑并吡啶和吡咯并吡啶,其用途和用于制备它们的中间体
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
CZ20032300A3 (cs) 2005-01-12
YU67803A (sh) 2006-08-17
RS50677B (sr) 2010-06-30
CA2439475A1 (en) 2002-09-06
KR20030087010A (ko) 2003-11-12
HUP0303243A2 (hu) 2004-01-28
MXPA03007717A (es) 2005-11-08
NZ527988A (en) 2006-01-27
IL157590A0 (en) 2004-03-28
EP1408953A1 (en) 2004-04-21
NO20033802L (no) 2003-10-22
ZA200307465B (en) 2005-03-17
WO2002067921A1 (en) 2002-09-06
HK1063436A1 (en) 2004-12-31
US6562867B2 (en) 2003-05-13
DE60210976T2 (de) 2007-05-24
DK1408953T3 (da) 2006-08-21
CN1505506A (zh) 2004-06-16
KR100946944B1 (ko) 2010-03-15
JP4276837B2 (ja) 2009-06-10
HUP0303243A3 (en) 2012-07-30
BR0207644A (pt) 2004-03-09
US20020198257A1 (en) 2002-12-26
RU2003128997A (ru) 2005-03-20
CY1105330T1 (el) 2010-03-03
EP1408953B1 (en) 2006-04-26
MY129304A (en) 2007-03-30
PT1408953E (pt) 2006-07-31
TWI250872B (en) 2006-03-11
ATE324108T1 (de) 2006-05-15
RU2300372C2 (ru) 2007-06-10
PL364638A1 (en) 2004-12-13
JP2004533415A (ja) 2004-11-04
ES2262801T3 (es) 2006-12-01
NO20033802D0 (no) 2003-08-26
CA2439475C (en) 2010-05-18
DE60210976D1 (de) 2006-06-01

Similar Documents

Publication Publication Date Title
CN1250214C (zh) 用于预防或治疗双相性精神障碍的氨基甲酸酯化合物
CN1250215C (zh) 用于预防或治疗双相性精神障碍的氨基甲酸酯化合物
JP5901528B2 (ja) 線維筋痛症候群の治療方法
CN1262272C (zh) 用于预防或治疗运动障碍的氨基甲酸酯化合物
CN1235579C (zh) 用于预防或治疗神经变性疾病的氨基甲酸酯化合物
AU2002242226A1 (en) Carbamate compounds for use in preventing or treating bipolar disorder
CN1250213C (zh) 用于预防或治疗神经性疼痛和丛集性头痛及有或没有先兆的偏头痛的氨基甲酸酯化合物
AU2002255580B2 (en) Carbamate compounds for use in preventing or treating bipolar disorder
HK1063436B (en) Carbamate compounds for use in preventing or treating bipolar disorder
AU2002255580A1 (en) Carbamate compounds for use in preventing or treating bipolar disorder
CN1555258A (zh) 用于预防或治疗神经性疼痛和丛集性头痛及偏头痛性疼痛的氨基甲酸酯化合物
CN1592617A (zh) 用于预防或治疗神经性疼痛和丛集性头痛及偏头痛性疼痛的氨基甲酸酯化合物
HK1058762B (en) Carbamate compounds for use in preventing or treating bipolar disorder
HK1073259A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060412

Termination date: 20120221